Hyperthermic intraperitoneal chemotherapy HIPEC

Hyperthermic intraperitoneal chemotherapy (HIPEC) is an innovative treatment for malignant tumors that involves the direct application of chemotherapy drugs heated to 42 degrees Celsius onto cancer cells.

The effectiveness of “hot chemotherapy” has been confirmed by numerous large-scale studies. The New England Journal of Medicine published data showing that the recurrence-free survival rate for mesothelioma (cancer of the lining that covers internal organs) reached 5 years, and the overall survival was 8 years.

Procedure specifics in global clinics

In leading international medical centers, HIPEC therapy is recognized as one of the most effective treatments for advanced-stage cancers. Its implementation requires expensive equipment, state-of-the-art surgical facilities, and a team of specially trained professionals, including surgeons, oncologists, and chemotherapy specialists.

Advantages of HIPEC therapy

• Well tolerated and does not cause systemic side effects: the drugs act only on the tissues of the abdominal cavity without entering the bloodstream
• Destroys single tumor cells, even those invisible to the naked eye
• Effective against both primary tumors and metastases: the high temperature of the drugs combined with cytostatic activity significantly increases treatment efficacy
• Reduces the risk of recurrence: according to clinical practice, the likelihood of tumor relapse is minimal